Christopher P. Evans

Also affiliated with Renown Health

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models”.

Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models

Pharmacological Research(2023)10.1016/j.phrs.2023.106692

N/A

0.681DataRank · unranked

22 citations

Joy C. Yang, Shu Ning, Bo Chen, Christopher Nip, Qiang Wei +7 more

Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment

medRxiv(2021)10.1101/2021.08.30.21262305

N/A

0.406DataRank · unranked

14 citations

Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki +92 more

Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2303

N/A

0DataRank · unranked

13 citations

Duanchen Sun, Eric Lu, Joshua A. Urrutia, Robert E. Reiter, Matthew B. Rettig +17 more

Autoantibody landscape of advanced prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.02.074575

N/A

0DataRank · unranked

0 citations

Winston Haynes, Rebecca Waitz, Kathy Kamath, Agustin Vega-Crespo, Raunak Shrestha +25 more

Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer

Scientific Reports(2021)10.1038/s41598-021-85969-x

N/A

0DataRank · unranked

85 citations

Chengfei Liu, Chun‐Yi Wu, Christopher P. Evans, Marc Dall’Era, Daniel Robles +5 more

Genetic factors associated with prostate cancer conversion from active surveillance to treatment

Human Genetics and Genomics Advances(2021)10.1016/j.xhgg.2021.100070

N/A

0DataRank · unranked

23 citations

Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki +92 more

How Should Molecular Markers and Magnetic Resonance Imaging Be Used in the Early Detection of Prostate Cancer?

European Urology Oncology(2021)10.1016/j.euo.2021.01.010

N/A

0DataRank · unranked

14 citations

Giorgio Ivan Russo, Hans Lilja, Christopher P. Evans, Jack A. Schalken, Eric A. Klein +2 more

Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling

Cancers(2021)10.3390/cancers13071672

N/A

0DataRank · unranked

14 citations

Zenghong Huang, Junjian Wang, Zhao Ma, Joy C. Yang, Eva Corey +4 more

5-hydroxymethylcytosine as a liquid biopsy biomarker in mCRPC.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.148

N/A

0DataRank · unranked

3 citations

Shuang G. Zhao, Eric J. Small, Yuhong Ning, Corinne Maurice‐Dror, Adam Foye +15 more

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-1123

N/A

0DataRank · unranked

67 citations

Shuang G. Zhao, Samuel Levy, Meng Zhang, Yuhong Ning, Raunak Shrestha +58 more

The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer

Biomedicines(2022)10.3390/biomedicines10081778

N/A

0DataRank · unranked

40 citations

Logan J. Wasielewski, Joy C. Yang, Demin Cai, Christopher P. Evans, William J. Murphy +2 more

Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006581

N/A

0DataRank · unranked

68 citations

Joy C. Yang, Bo Chen, Christopher Nip, Jonathan E Van Dyke, Xiong Zhang +5 more

Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer

Oncogene(2023)10.1038/s41388-022-02566-6

N/A

0DataRank · unranked

21 citations

Pengfei Xu, Shu Ning, Logan J. Wasielewski, Hans Adomat, Sung Hee Hwang +9 more

895 Immunosuppressive signaling is activated in enzalutamide resistant prostate cancer

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0895

N/A

0DataRank · unranked

0 citations

Joy C. Yang, Bo Chen, Christopher Nip, Leyi Wang, Jonathan E. Van Dyke +4 more

Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer

Nature Genetics(2024)10.1038/s41588-024-01826-3

N/A

0DataRank · unranked

38 citations

Matthew L. Bootsma, Stanley Zhou, Raunak Shrestha, Thaidy Moreno-Rodriguez, Arian Lundberg +41 more

Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate Cancer

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0015

N/A

0DataRank · unranked

82 citations

Shu Ning, Wei Lou, Joy C. Yang, Cameron M. Armstrong, Alan P. Lombard +5 more

Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer

Nature Communications(2024)10.1038/s41467-024-50459-x

N/A

0DataRank · unranked

10 citations

Joy C. Yang, Bo Chen, Shu Ning, Xiong Zhang, Leyi Wang +16 more

Autoantibody Landscape in Patients with Advanced Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1966

N/A

0DataRank · unranked

20 citations

Winston Haynes, Rebecca Waitz, Kathy Kamath, Agustin Vega-Crespo, Raunak Shrestha +26 more